A comprehensive lesson on abnormal cellular growth and its clinical significance
Dysplasia refers to abnormal cellular growth with altered size, shape, and organization. It represents a step toward neoplastic transformation, existing on a spectrum of cellular abnormalities that may progress to cancer.
Key Point: Dysplasia is characterized by cellular abnormalities but without invasion through the basement membrane. Once invasion occurs, it becomes invasive carcinoma.
Important: The distinction between severe dysplasia and carcinoma in situ varies by organ system, but both represent the highest grade of pre-invasive disease.
Caused by persistent HPV infection. Classified as CIN (cervical intraepithelial neoplasia) grades 1-3 or as low/high-grade squamous intraepithelial lesions (LSIL/HSIL).
Seen in long-standing IBD (ulcerative colitis, Crohn's). Risk increases after 8-10 years of disease. Requires surveillance colonoscopies with biopsies.
Often presents as leukoplakia (white patches). Strongly associated with tobacco use. Requires biopsy for definitive diagnosis and grading.
Clinical Approach: Management depends on grade and location. Options range from surveillance (mild) to excision (severe). All high-grade dysplasias require intervention.
Dysplasia represents abnormal cellular growth with altered size, shape, and organization. It exists on a spectrum from mild to severe (carcinoma in situ) and has potential to progress to invasive cancer if untreated.
Key features include cellular pleomorphism, nuclear abnormalities, and architectural distortion. Clinical examples include cervical (HPV-related), colonic (IBD-related), and oral (tobacco-related) dysplasias.
Dysplasia = Precancerous cellular abnormalities | Graded mild/moderate/severe | Requires appropriate monitoring/intervention
Answer these 5 questions to test your understanding
Your performance on the Dysplasia Knowledge Test
Loading your results...